Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians

被引：5
作者：
Dieterle, Martin Philipp [1 ,2 ]
Mostufi-Zadeh-Haghighi, Gila [1 ]
Kus, Jan Wilhelm [1 ]
Wippel, Christopher [1 ]
Brugger, Zacharias [1 ]
Miething, Cornelius [1 ]
Waesch, Ralph [1 ]
Engelhardt, Monika [1 ]
机构：
[1] Univ Freiburg, Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Fac Med, Freiburg, Germany
[2] Univ Freiburg, Ctr Dent Med, Div Oral Biotechnol, Med Ctr,Fac Med, Hugstetterstr 55, D-79106 Freiburg, Germany
来源：
ANNALS OF HEMATOLOGY | 2023年 / 102卷 / 12期
关键词：
D O I：
10.1007/s00277-023-05451-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3639 / 3641
页数：3
相关论文
共 10 条
[1]  
[Anonymous], 2017, Common Terminology Criteria for Adverse Events (CTCAE)
[2]   A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients [J].
Engelhardt, Monika ;
Domm, Anne-Saskia ;
Dold, Sandra Maria ;
Ihorst, Gabriele ;
Reinhardt, Heike ;
Zober, Alexander ;
Hieke, Stefanie ;
Baayen, Corine ;
Mueller, Stefan Jurgen ;
Einsele, Hermann ;
Sonneveld, Pieter ;
Landgren, Ola ;
Schumacher, Martin ;
Waesch, Ralph .
HAEMATOLOGICA, 2017, 102 (05) :910-921
[3]   Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores [J].
Engelhardt, Monika ;
Dold, Sandra Maria ;
Ihorst, Gabriele ;
Zober, Alexander ;
Moeller, Mandy ;
Reinhardt, Heike ;
Hieke, Stefanie ;
Schumacher, Martin ;
Waesch, Ralph .
HAEMATOLOGICA, 2016, 101 (09) :1110-1119
[4]   Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma [J].
Martin, Thomas G. ;
Mateos, Maria Victoria ;
Nooka, Ajay ;
Banerjee, Arnob ;
Kobos, Rachel ;
Pei, Lixia ;
Qi, Ming ;
Verona, Raluca ;
Doyle, Margaret ;
Smit, Jennifer ;
Sun, Weili ;
Trancucci, Danielle ;
Uhlar, Clarissa ;
van de Donk, Niels W. C. J. ;
Rodriguez, Cesar .
CANCER, 2023, 129 (13) :2035-2046
[5]   Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma [J].
Mateos, Maria-Victoria ;
Chari, Ajai ;
Usmani, Saad Z. ;
Goldschmidt, Hartmut ;
Weisel, Katja ;
Qi, Keqin ;
Londhe, Anil ;
Nair, Sandhya ;
Lin, Xiwu ;
Pei, Lixia ;
Ammann, Eric ;
Kobos, Rachel ;
Smit, Jennifer ;
Parekh, Trilok ;
Marshall, Alexander ;
Slavcev, Mary ;
Moreau, Philippe .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (05) :385-393
[6]   Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma [J].
Moreau, Philippe ;
van de Donk, Niels W. C. J. ;
Delforge, Michel ;
Einsele, Hermann ;
De Stefano, Valerio ;
Perrot, Aurore ;
Besemer, Britta ;
Pawlyn, Charlotte ;
Karlin, Lionel ;
Manier, Salomon ;
Leleu, Xavier ;
Weisel, Katja ;
Ghilotti, Francesca ;
Diels, Joris ;
Elsada, Ahmed ;
Morano, Raul ;
Strulev, Vadim ;
Pei, Lixia ;
Kobos, Rachel ;
Smit, Jennifer ;
Slavcev, Mary ;
Mateos, Maria-Victoria .
ADVANCES IN THERAPY, 2023, 40 (05) :2412-2425
[7]   Blinatumomab as salvage therapy in patients with relapsed/refractory B-ALL who have failed/progressed after anti-CD19-CAR T therapy [J].
Qi, Yao ;
Liu, Hong ;
Li, Xin ;
Shi, Yin ;
Mu, Juan ;
Li, Jingyi ;
Wang, Ying ;
Deng, Qi .
ANNALS OF MEDICINE, 2023, 55 (01)
[8]   Novel immunotherapies in multiple myeloma - chances and challenges [J].
Rasche, Leo ;
Wasch, Ralph ;
Munder, Markus ;
Goldschmidt, Hartmut ;
Raab, Marc S. .
HAEMATOLOGICA, 2021, 106 (10) :2555-2565
[9]   Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives [J].
Shrivastava, Trilok ;
Van Rhee, Frits ;
Al Hadidi, Samer .
ONCOTARGETS AND THERAPY, 2023, 16 :441-464
[10]   Teclistamab, a B-cell maturation antigenxCD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study [J].
Usmani, Saad Z. ;
Garfall, Alfred L. ;
van de Donk, Niels W. C. J. ;
Nahi, Hareth ;
San-Miguel, Jesus F. ;
Oriol, Albert ;
Rosinol, Laura ;
Chari, Ajai ;
Bhutani, Manisha ;
Karlin, Lionel ;
Benboubker, Lotfi ;
Pei, Lixia ;
Verona, Raluca ;
Girgis, Suzette ;
Stephenson, Tara ;
Elsayed, Yusri ;
Infante, Jeffrey ;
Goldberg, Jenna D. ;
Banerjee, Arnob ;
Mateos, Maria-Victoria ;
Krishnan, Amrita .
LANCET, 2021, 398 (10301) :665-674
1